Holiday Alone Time; Depression Indication for Antipsychotic? Lithium and CKD

More than half of respondents in a national survey from Ohio State University said it’s very important to their mental health to have adequate time alone during the holidays.

Psychological interventions helped prevent the onset of major depressive disorder in adults with subthreshold depressive symptoms, a 30-trial meta-analysis found. (Lancet Psychiatry)

Intra-Cellular Therapies submitted a supplemental new drug application to the FDA for lumateperone (Caplyta) as a potential adjunctive treatment to antidepressants for major depressive disorder, along with supporting phase III data. The atypical antipsychotic is approved for schizophrenia and bipolar disorder.

High rates of undiagnosed depression and other psychiatric ailments among patients with cancer remain a large concern. (NBC News)

Residents and fellows at George Washington University Hospital in Washington, D.C., voted to strike, demanding pay increases and more robust mental health benefits. (Washington Post)

People treated with lithium for mood disorders had an increased risk of developing stage 3 or higher chronic kidney disease (CKD) in a blood concentration-dependent manner, according to a retrospective study in Iceland. (Lancet Psychiatry)

Traffic noise masked the positive mental health effect that natural sounds, like birds chirping, had on stress and anxiety. (PLOS One)

Could co-housing combat America’s loneliness problem? (NPR)

Outpatient psychotherapy use rose preferentially among socioeconomically advantaged adults with mild or moderate distress from 2018 to 2021, cross-sectional data showed. (JAMA Psychiatry)